Professor Martin O’Donnell leads the Neurovascular Research Group dedicated to advancing knowledge and understanding in the field of Neurovascular diseases, with a primary focus on the prevention of stroke and cognitive impairment/dementia. Our core objectives are to:
  1. Conduct innovative research to identify risk factors, biomarkers, and therapeutic targets related to stroke and cognitive impairment/dementia.
  2. Investigate the underlying mechanisms contributing to neurovascular diseases through rigorous scientific investigation.
  3. Disseminate research findings through:
    • Peer-reviewed publications
    • Conference presentations
    • Educational initiatives for patients and healthcare professionals
    • Engagement with the broader scientific community
  4. Advance the field through systematic reviews and meta-analyses to synthesize current evidence and identify knowledge gaps.